Vorinostat (Zolinza)

vorinostat · Merck & Co.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Vorinostat (Zolinza), covering 2010-02-15 to 2025-07-10. Get the full timeline:

Most recent: Clinical Trial Update: HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma [Phase 1, Phase 2]